Concepedia

Philip Hamann

PH

Statistics

Publications

10

Citations

455

H-Index

10

Active since

1992

Affiliations

University of Bristol(Current)

University of Bath

University of Manchester

Royal National Hospital for Rheumatic Diseases

University of Exeter

Philip Hamann is an author at University of Bristol specializing in medicine, oncology, and rheumatoid arthritis.

Publications per year

1992–2023

10

Publications

10

Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.

Oliver W. Press, Darning Shan, J Howell-Clark et al. · PubMed · 1996 · 212 citations

Medicine, Nuclear Medicine, Oncology +13

Tumoricidal effect of calicheamicin immuno-conjugates using a passive targeting strategy

Erwin R. Boghaert, Kiran Khandke, Latha Sridharan et al. · International Journal of Oncology · 2006 · 46 citations

Medicine, Oncology, Pharmacology +17

The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin

Erwin R. Boghaert, Latha Sridharan, Kiran Khandke et al. · International Journal of Oncology · 2008 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis

Philip Hamann, Benoît Roux, James A. Heward et al. · Scientific Reports · 2017 · 41 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients

Philip Hamann, John D Pauling, Neil McHugh et al. · Lara D. Veeken · 2019 · 41 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

1–5 of 10